MAPKAPK2 and inflammatory bowel disease: Some articles reported that MK2 prevents premature export of NF-κB from the nucleus in inflammatory diseases [22,23], suggesting that NF-κB signaling suppression may also contribute to the protective role for MMI-0100 in experimental IBD.